Answers are grounded in this paper and cite their sources.
Gene sequencing has brought a titanic of complex data into clinical precision oncology. Deciphering this complexity for practice requires new constructs. In 2014, the Molecular Tumor Board (MTB) was introduced into the literature by a publication in The Oncologist. Ten years later, MTBs have become globally established vehicles that integrate rapidly emerging "omic" information, helping to transform cancer management.
No takes yet. Share an insight, caveat, or question.
Wahida et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: